Medical Care
Cardiology Point-of-Care (POC) Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Sep 18, 24
- ID: 550880
- Pages: 107
- Figures: 190
- Views: 1
The global market for Cardiology Point-of-Care (POC) Diagnostics was estimated to be worth US$ 134.6 million in 2023 and is forecast to a readjusted size of US$ 233.7 million by 2030 with a CAGR of 8.2% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cardiology Point-of-Care (POC) Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Cardiology Point-of-Care (POC) Diagnostics by region & country, by Type, and by Application.
The Cardiology Point-of-Care (POC) Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiology Point-of-Care (POC) Diagnostics.
Market Segmentation
By Company
Siemens
Abbott
Roche
Opko
GE Healthcare
Samsung Health
BioMerieux
Abbott
Terumo
Accriva
Akers
Radiometer
Response Biomedical
Segment by Type:
Cardiometabolic Monitoring
Cardiometabolic Diagnostics
Segment by Application
Professional Diagnostic Centers
Hospitals/Critical Care Centers
Research Laboratories
Home Care
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cardiology Point-of-Care (POC) Diagnostics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Cardiology Point-of-Care (POC) Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Cardiology Point-of-Care (POC) Diagnostics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cardiology Point-of-Care (POC) Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Cardiology Point-of-Care (POC) Diagnostics by region & country, by Type, and by Application.
The Cardiology Point-of-Care (POC) Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiology Point-of-Care (POC) Diagnostics.
Market Segmentation
By Company
Siemens
Abbott
Roche
Opko
GE Healthcare
Samsung Health
BioMerieux
Abbott
Terumo
Accriva
Akers
Radiometer
Response Biomedical
Segment by Type:
Cardiometabolic Monitoring
Cardiometabolic Diagnostics
Segment by Application
Professional Diagnostic Centers
Hospitals/Critical Care Centers
Research Laboratories
Home Care
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cardiology Point-of-Care (POC) Diagnostics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Cardiology Point-of-Care (POC) Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Cardiology Point-of-Care (POC) Diagnostics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Cardiology Point-of-Care (POC) Diagnostics Product Introduction
1.2 Global Cardiology Point-of-Care (POC) Diagnostics Market Size Forecast
1.3 Cardiology Point-of-Care (POC) Diagnostics Market Trends & Drivers
1.3.1 Cardiology Point-of-Care (POC) Diagnostics Industry Trends
1.3.2 Cardiology Point-of-Care (POC) Diagnostics Market Drivers & Opportunity
1.3.3 Cardiology Point-of-Care (POC) Diagnostics Market Challenges
1.3.4 Cardiology Point-of-Care (POC) Diagnostics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cardiology Point-of-Care (POC) Diagnostics Players Revenue Ranking (2023)
2.2 Global Cardiology Point-of-Care (POC) Diagnostics Revenue by Company (2019-2024)
2.3 Key Companies Cardiology Point-of-Care (POC) Diagnostics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Cardiology Point-of-Care (POC) Diagnostics Product Offered
2.5 Key Companies Time to Begin Mass Production of Cardiology Point-of-Care (POC) Diagnostics
2.6 Cardiology Point-of-Care (POC) Diagnostics Market Competitive Analysis
2.6.1 Cardiology Point-of-Care (POC) Diagnostics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Cardiology Point-of-Care (POC) Diagnostics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiology Point-of-Care (POC) Diagnostics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Cardiometabolic Monitoring
3.1.2 Cardiometabolic Diagnostics
3.2 Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type
3.2.1 Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Cardiology Point-of-Care (POC) Diagnostics Sales Value, by Type (2019-2030)
3.2.3 Global Cardiology Point-of-Care (POC) Diagnostics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Professional Diagnostic Centers
4.1.2 Hospitals/Critical Care Centers
4.1.3 Research Laboratories
4.1.4 Home Care
4.2 Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application
4.2.1 Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Cardiology Point-of-Care (POC) Diagnostics Sales Value, by Application (2019-2030)
4.2.3 Global Cardiology Point-of-Care (POC) Diagnostics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Region
5.1.1 Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Region (2019-2024)
5.1.3 Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Region (2025-2030)
5.1.4 Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Cardiology Point-of-Care (POC) Diagnostics Sales Value, 2019-2030
5.2.2 North America Cardiology Point-of-Care (POC) Diagnostics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Cardiology Point-of-Care (POC) Diagnostics Sales Value, 2019-2030
5.3.2 Europe Cardiology Point-of-Care (POC) Diagnostics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Cardiology Point-of-Care (POC) Diagnostics Sales Value, 2019-2030
5.4.2 Asia Pacific Cardiology Point-of-Care (POC) Diagnostics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Cardiology Point-of-Care (POC) Diagnostics Sales Value, 2019-2030
5.5.2 South America Cardiology Point-of-Care (POC) Diagnostics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Cardiology Point-of-Care (POC) Diagnostics Sales Value, 2019-2030
5.6.2 Middle East & Africa Cardiology Point-of-Care (POC) Diagnostics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cardiology Point-of-Care (POC) Diagnostics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Cardiology Point-of-Care (POC) Diagnostics Sales Value
6.3 United States
6.3.1 United States Cardiology Point-of-Care (POC) Diagnostics Sales Value, 2019-2030
6.3.2 United States Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Cardiology Point-of-Care (POC) Diagnostics Sales Value, 2019-2030
6.4.2 Europe Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Cardiology Point-of-Care (POC) Diagnostics Sales Value, 2019-2030
6.5.2 China Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Cardiology Point-of-Care (POC) Diagnostics Sales Value, 2019-2030
6.6.2 Japan Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Cardiology Point-of-Care (POC) Diagnostics Sales Value, 2019-2030
6.7.2 South Korea Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Cardiology Point-of-Care (POC) Diagnostics Sales Value, 2019-2030
6.8.2 Southeast Asia Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Cardiology Point-of-Care (POC) Diagnostics Sales Value, 2019-2030
6.9.2 India Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Siemens
7.1.1 Siemens Profile
7.1.2 Siemens Main Business
7.1.3 Siemens Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
7.1.4 Siemens Cardiology Point-of-Care (POC) Diagnostics Revenue (US$ Million) & (2019-2024)
7.1.5 Siemens Recent Developments
7.2 Abbott
7.2.1 Abbott Profile
7.2.2 Abbott Main Business
7.2.3 Abbott Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
7.2.4 Abbott Cardiology Point-of-Care (POC) Diagnostics Revenue (US$ Million) & (2019-2024)
7.2.5 Abbott Recent Developments
7.3 Roche
7.3.1 Roche Profile
7.3.2 Roche Main Business
7.3.3 Roche Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
7.3.4 Roche Cardiology Point-of-Care (POC) Diagnostics Revenue (US$ Million) & (2019-2024)
7.3.5 Opko Recent Developments
7.4 Opko
7.4.1 Opko Profile
7.4.2 Opko Main Business
7.4.3 Opko Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
7.4.4 Opko Cardiology Point-of-Care (POC) Diagnostics Revenue (US$ Million) & (2019-2024)
7.4.5 Opko Recent Developments
7.5 GE Healthcare
7.5.1 GE Healthcare Profile
7.5.2 GE Healthcare Main Business
7.5.3 GE Healthcare Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
7.5.4 GE Healthcare Cardiology Point-of-Care (POC) Diagnostics Revenue (US$ Million) & (2019-2024)
7.5.5 GE Healthcare Recent Developments
7.6 Samsung Health
7.6.1 Samsung Health Profile
7.6.2 Samsung Health Main Business
7.6.3 Samsung Health Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
7.6.4 Samsung Health Cardiology Point-of-Care (POC) Diagnostics Revenue (US$ Million) & (2019-2024)
7.6.5 Samsung Health Recent Developments
7.7 BioMerieux
7.7.1 BioMerieux Profile
7.7.2 BioMerieux Main Business
7.7.3 BioMerieux Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
7.7.4 BioMerieux Cardiology Point-of-Care (POC) Diagnostics Revenue (US$ Million) & (2019-2024)
7.7.5 BioMerieux Recent Developments
7.8 Abbott
7.8.1 Abbott Profile
7.8.2 Abbott Main Business
7.8.3 Abbott Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
7.8.4 Abbott Cardiology Point-of-Care (POC) Diagnostics Revenue (US$ Million) & (2019-2024)
7.8.5 Abbott Recent Developments
7.9 Terumo
7.9.1 Terumo Profile
7.9.2 Terumo Main Business
7.9.3 Terumo Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
7.9.4 Terumo Cardiology Point-of-Care (POC) Diagnostics Revenue (US$ Million) & (2019-2024)
7.9.5 Terumo Recent Developments
7.10 Accriva
7.10.1 Accriva Profile
7.10.2 Accriva Main Business
7.10.3 Accriva Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
7.10.4 Accriva Cardiology Point-of-Care (POC) Diagnostics Revenue (US$ Million) & (2019-2024)
7.10.5 Accriva Recent Developments
7.11 Akers
7.11.1 Akers Profile
7.11.2 Akers Main Business
7.11.3 Akers Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
7.11.4 Akers Cardiology Point-of-Care (POC) Diagnostics Revenue (US$ Million) & (2019-2024)
7.11.5 Akers Recent Developments
7.12 Radiometer
7.12.1 Radiometer Profile
7.12.2 Radiometer Main Business
7.12.3 Radiometer Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
7.12.4 Radiometer Cardiology Point-of-Care (POC) Diagnostics Revenue (US$ Million) & (2019-2024)
7.12.5 Radiometer Recent Developments
7.13 Response Biomedical
7.13.1 Response Biomedical Profile
7.13.2 Response Biomedical Main Business
7.13.3 Response Biomedical Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
7.13.4 Response Biomedical Cardiology Point-of-Care (POC) Diagnostics Revenue (US$ Million) & (2019-2024)
7.13.5 Response Biomedical Recent Developments
8 Industry Chain Analysis
8.1 Cardiology Point-of-Care (POC) Diagnostics Industrial Chain
8.2 Cardiology Point-of-Care (POC) Diagnostics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Cardiology Point-of-Care (POC) Diagnostics Sales Model
8.5.2 Sales Channel
8.5.3 Cardiology Point-of-Care (POC) Diagnostics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Cardiology Point-of-Care (POC) Diagnostics Product Introduction
1.2 Global Cardiology Point-of-Care (POC) Diagnostics Market Size Forecast
1.3 Cardiology Point-of-Care (POC) Diagnostics Market Trends & Drivers
1.3.1 Cardiology Point-of-Care (POC) Diagnostics Industry Trends
1.3.2 Cardiology Point-of-Care (POC) Diagnostics Market Drivers & Opportunity
1.3.3 Cardiology Point-of-Care (POC) Diagnostics Market Challenges
1.3.4 Cardiology Point-of-Care (POC) Diagnostics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cardiology Point-of-Care (POC) Diagnostics Players Revenue Ranking (2023)
2.2 Global Cardiology Point-of-Care (POC) Diagnostics Revenue by Company (2019-2024)
2.3 Key Companies Cardiology Point-of-Care (POC) Diagnostics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Cardiology Point-of-Care (POC) Diagnostics Product Offered
2.5 Key Companies Time to Begin Mass Production of Cardiology Point-of-Care (POC) Diagnostics
2.6 Cardiology Point-of-Care (POC) Diagnostics Market Competitive Analysis
2.6.1 Cardiology Point-of-Care (POC) Diagnostics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Cardiology Point-of-Care (POC) Diagnostics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiology Point-of-Care (POC) Diagnostics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Cardiometabolic Monitoring
3.1.2 Cardiometabolic Diagnostics
3.2 Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type
3.2.1 Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Cardiology Point-of-Care (POC) Diagnostics Sales Value, by Type (2019-2030)
3.2.3 Global Cardiology Point-of-Care (POC) Diagnostics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Professional Diagnostic Centers
4.1.2 Hospitals/Critical Care Centers
4.1.3 Research Laboratories
4.1.4 Home Care
4.2 Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application
4.2.1 Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Cardiology Point-of-Care (POC) Diagnostics Sales Value, by Application (2019-2030)
4.2.3 Global Cardiology Point-of-Care (POC) Diagnostics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Region
5.1.1 Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Region (2019-2024)
5.1.3 Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Region (2025-2030)
5.1.4 Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Cardiology Point-of-Care (POC) Diagnostics Sales Value, 2019-2030
5.2.2 North America Cardiology Point-of-Care (POC) Diagnostics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Cardiology Point-of-Care (POC) Diagnostics Sales Value, 2019-2030
5.3.2 Europe Cardiology Point-of-Care (POC) Diagnostics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Cardiology Point-of-Care (POC) Diagnostics Sales Value, 2019-2030
5.4.2 Asia Pacific Cardiology Point-of-Care (POC) Diagnostics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Cardiology Point-of-Care (POC) Diagnostics Sales Value, 2019-2030
5.5.2 South America Cardiology Point-of-Care (POC) Diagnostics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Cardiology Point-of-Care (POC) Diagnostics Sales Value, 2019-2030
5.6.2 Middle East & Africa Cardiology Point-of-Care (POC) Diagnostics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cardiology Point-of-Care (POC) Diagnostics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Cardiology Point-of-Care (POC) Diagnostics Sales Value
6.3 United States
6.3.1 United States Cardiology Point-of-Care (POC) Diagnostics Sales Value, 2019-2030
6.3.2 United States Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Cardiology Point-of-Care (POC) Diagnostics Sales Value, 2019-2030
6.4.2 Europe Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Cardiology Point-of-Care (POC) Diagnostics Sales Value, 2019-2030
6.5.2 China Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Cardiology Point-of-Care (POC) Diagnostics Sales Value, 2019-2030
6.6.2 Japan Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Cardiology Point-of-Care (POC) Diagnostics Sales Value, 2019-2030
6.7.2 South Korea Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Cardiology Point-of-Care (POC) Diagnostics Sales Value, 2019-2030
6.8.2 Southeast Asia Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Cardiology Point-of-Care (POC) Diagnostics Sales Value, 2019-2030
6.9.2 India Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Siemens
7.1.1 Siemens Profile
7.1.2 Siemens Main Business
7.1.3 Siemens Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
7.1.4 Siemens Cardiology Point-of-Care (POC) Diagnostics Revenue (US$ Million) & (2019-2024)
7.1.5 Siemens Recent Developments
7.2 Abbott
7.2.1 Abbott Profile
7.2.2 Abbott Main Business
7.2.3 Abbott Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
7.2.4 Abbott Cardiology Point-of-Care (POC) Diagnostics Revenue (US$ Million) & (2019-2024)
7.2.5 Abbott Recent Developments
7.3 Roche
7.3.1 Roche Profile
7.3.2 Roche Main Business
7.3.3 Roche Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
7.3.4 Roche Cardiology Point-of-Care (POC) Diagnostics Revenue (US$ Million) & (2019-2024)
7.3.5 Opko Recent Developments
7.4 Opko
7.4.1 Opko Profile
7.4.2 Opko Main Business
7.4.3 Opko Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
7.4.4 Opko Cardiology Point-of-Care (POC) Diagnostics Revenue (US$ Million) & (2019-2024)
7.4.5 Opko Recent Developments
7.5 GE Healthcare
7.5.1 GE Healthcare Profile
7.5.2 GE Healthcare Main Business
7.5.3 GE Healthcare Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
7.5.4 GE Healthcare Cardiology Point-of-Care (POC) Diagnostics Revenue (US$ Million) & (2019-2024)
7.5.5 GE Healthcare Recent Developments
7.6 Samsung Health
7.6.1 Samsung Health Profile
7.6.2 Samsung Health Main Business
7.6.3 Samsung Health Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
7.6.4 Samsung Health Cardiology Point-of-Care (POC) Diagnostics Revenue (US$ Million) & (2019-2024)
7.6.5 Samsung Health Recent Developments
7.7 BioMerieux
7.7.1 BioMerieux Profile
7.7.2 BioMerieux Main Business
7.7.3 BioMerieux Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
7.7.4 BioMerieux Cardiology Point-of-Care (POC) Diagnostics Revenue (US$ Million) & (2019-2024)
7.7.5 BioMerieux Recent Developments
7.8 Abbott
7.8.1 Abbott Profile
7.8.2 Abbott Main Business
7.8.3 Abbott Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
7.8.4 Abbott Cardiology Point-of-Care (POC) Diagnostics Revenue (US$ Million) & (2019-2024)
7.8.5 Abbott Recent Developments
7.9 Terumo
7.9.1 Terumo Profile
7.9.2 Terumo Main Business
7.9.3 Terumo Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
7.9.4 Terumo Cardiology Point-of-Care (POC) Diagnostics Revenue (US$ Million) & (2019-2024)
7.9.5 Terumo Recent Developments
7.10 Accriva
7.10.1 Accriva Profile
7.10.2 Accriva Main Business
7.10.3 Accriva Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
7.10.4 Accriva Cardiology Point-of-Care (POC) Diagnostics Revenue (US$ Million) & (2019-2024)
7.10.5 Accriva Recent Developments
7.11 Akers
7.11.1 Akers Profile
7.11.2 Akers Main Business
7.11.3 Akers Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
7.11.4 Akers Cardiology Point-of-Care (POC) Diagnostics Revenue (US$ Million) & (2019-2024)
7.11.5 Akers Recent Developments
7.12 Radiometer
7.12.1 Radiometer Profile
7.12.2 Radiometer Main Business
7.12.3 Radiometer Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
7.12.4 Radiometer Cardiology Point-of-Care (POC) Diagnostics Revenue (US$ Million) & (2019-2024)
7.12.5 Radiometer Recent Developments
7.13 Response Biomedical
7.13.1 Response Biomedical Profile
7.13.2 Response Biomedical Main Business
7.13.3 Response Biomedical Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
7.13.4 Response Biomedical Cardiology Point-of-Care (POC) Diagnostics Revenue (US$ Million) & (2019-2024)
7.13.5 Response Biomedical Recent Developments
8 Industry Chain Analysis
8.1 Cardiology Point-of-Care (POC) Diagnostics Industrial Chain
8.2 Cardiology Point-of-Care (POC) Diagnostics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Cardiology Point-of-Care (POC) Diagnostics Sales Model
8.5.2 Sales Channel
8.5.3 Cardiology Point-of-Care (POC) Diagnostics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Cardiology Point-of-Care (POC) Diagnostics Market Trends
Table 2. Cardiology Point-of-Care (POC) Diagnostics Market Drivers & Opportunity
Table 3. Cardiology Point-of-Care (POC) Diagnostics Market Challenges
Table 4. Cardiology Point-of-Care (POC) Diagnostics Market Restraints
Table 5. Global Cardiology Point-of-Care (POC) Diagnostics Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Cardiology Point-of-Care (POC) Diagnostics Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Cardiology Point-of-Care (POC) Diagnostics Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Cardiology Point-of-Care (POC) Diagnostics Product Type
Table 9. Key Companies Time to Begin Mass Production of Cardiology Point-of-Care (POC) Diagnostics
Table 10. Global Cardiology Point-of-Care (POC) Diagnostics Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiology Point-of-Care (POC) Diagnostics as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Cardiology Point-of-Care (POC) Diagnostics Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Cardiology Point-of-Care (POC) Diagnostics Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Cardiology Point-of-Care (POC) Diagnostics Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Cardiology Point-of-Care (POC) Diagnostics Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Region (2019-2024) & (%)
Table 27. Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Cardiology Point-of-Care (POC) Diagnostics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Cardiology Point-of-Care (POC) Diagnostics Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Cardiology Point-of-Care (POC) Diagnostics Sales Value, (2025-2030) & (US$ Million)
Table 31. Siemens Basic Information List
Table 32. Siemens Description and Business Overview
Table 33. Siemens Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
Table 34. Revenue (US$ Million) in Cardiology Point-of-Care (POC) Diagnostics Business of Siemens (2019-2024)
Table 35. Siemens Recent Developments
Table 36. Abbott Basic Information List
Table 37. Abbott Description and Business Overview
Table 38. Abbott Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
Table 39. Revenue (US$ Million) in Cardiology Point-of-Care (POC) Diagnostics Business of Abbott (2019-2024)
Table 40. Abbott Recent Developments
Table 41. Roche Basic Information List
Table 42. Roche Description and Business Overview
Table 43. Roche Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
Table 44. Revenue (US$ Million) in Cardiology Point-of-Care (POC) Diagnostics Business of Roche (2019-2024)
Table 45. Roche Recent Developments
Table 46. Opko Basic Information List
Table 47. Opko Description and Business Overview
Table 48. Opko Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
Table 49. Revenue (US$ Million) in Cardiology Point-of-Care (POC) Diagnostics Business of Opko (2019-2024)
Table 50. Opko Recent Developments
Table 51. GE Healthcare Basic Information List
Table 52. GE Healthcare Description and Business Overview
Table 53. GE Healthcare Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
Table 54. Revenue (US$ Million) in Cardiology Point-of-Care (POC) Diagnostics Business of GE Healthcare (2019-2024)
Table 55. GE Healthcare Recent Developments
Table 56. Samsung Health Basic Information List
Table 57. Samsung Health Description and Business Overview
Table 58. Samsung Health Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
Table 59. Revenue (US$ Million) in Cardiology Point-of-Care (POC) Diagnostics Business of Samsung Health (2019-2024)
Table 60. Samsung Health Recent Developments
Table 61. BioMerieux Basic Information List
Table 62. BioMerieux Description and Business Overview
Table 63. BioMerieux Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
Table 64. Revenue (US$ Million) in Cardiology Point-of-Care (POC) Diagnostics Business of BioMerieux (2019-2024)
Table 65. BioMerieux Recent Developments
Table 66. Abbott Basic Information List
Table 67. Abbott Description and Business Overview
Table 68. Abbott Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
Table 69. Revenue (US$ Million) in Cardiology Point-of-Care (POC) Diagnostics Business of Abbott (2019-2024)
Table 70. Abbott Recent Developments
Table 71. Terumo Basic Information List
Table 72. Terumo Description and Business Overview
Table 73. Terumo Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
Table 74. Revenue (US$ Million) in Cardiology Point-of-Care (POC) Diagnostics Business of Terumo (2019-2024)
Table 75. Terumo Recent Developments
Table 76. Accriva Basic Information List
Table 77. Accriva Description and Business Overview
Table 78. Accriva Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
Table 79. Revenue (US$ Million) in Cardiology Point-of-Care (POC) Diagnostics Business of Accriva (2019-2024)
Table 80. Accriva Recent Developments
Table 81. Akers Basic Information List
Table 82. Akers Description and Business Overview
Table 83. Akers Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
Table 84. Revenue (US$ Million) in Cardiology Point-of-Care (POC) Diagnostics Business of Akers (2019-2024)
Table 85. Akers Recent Developments
Table 86. Radiometer Basic Information List
Table 87. Radiometer Description and Business Overview
Table 88. Radiometer Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
Table 89. Revenue (US$ Million) in Cardiology Point-of-Care (POC) Diagnostics Business of Radiometer (2019-2024)
Table 90. Radiometer Recent Developments
Table 91. Response Biomedical Basic Information List
Table 92. Response Biomedical Description and Business Overview
Table 93. Response Biomedical Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
Table 94. Revenue (US$ Million) in Cardiology Point-of-Care (POC) Diagnostics Business of Response Biomedical (2019-2024)
Table 95. Response Biomedical Recent Developments
Table 96. Key Raw Materials Lists
Table 97. Raw Materials Key Suppliers Lists
Table 98. Cardiology Point-of-Care (POC) Diagnostics Downstream Customers
Table 99. Cardiology Point-of-Care (POC) Diagnostics Distributors List
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Cardiology Point-of-Care (POC) Diagnostics Product Picture
Figure 2. Global Cardiology Point-of-Care (POC) Diagnostics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Cardiology Point-of-Care (POC) Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 4. Cardiology Point-of-Care (POC) Diagnostics Report Years Considered
Figure 5. Global Cardiology Point-of-Care (POC) Diagnostics Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Cardiology Point-of-Care (POC) Diagnostics Revenue in 2023
Figure 7. Cardiology Point-of-Care (POC) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Cardiometabolic Monitoring Picture
Figure 9. Cardiometabolic Diagnostics Picture
Figure 10. Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Cardiology Point-of-Care (POC) Diagnostics Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Professional Diagnostic Centers
Figure 13. Product Picture of Hospitals/Critical Care Centers
Figure 14. Product Picture of Research Laboratories
Figure 15. Product Picture of Home Care
Figure 16. Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Cardiology Point-of-Care (POC) Diagnostics Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America Cardiology Point-of-Care (POC) Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 19. North America Cardiology Point-of-Care (POC) Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe Cardiology Point-of-Care (POC) Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe Cardiology Point-of-Care (POC) Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific Cardiology Point-of-Care (POC) Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific Cardiology Point-of-Care (POC) Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 24. South America Cardiology Point-of-Care (POC) Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 25. South America Cardiology Point-of-Care (POC) Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa Cardiology Point-of-Care (POC) Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa Cardiology Point-of-Care (POC) Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions Cardiology Point-of-Care (POC) Diagnostics Sales Value (%), (2019-2030)
Figure 29. United States Cardiology Point-of-Care (POC) Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 31. United States Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe Cardiology Point-of-Care (POC) Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 35. China Cardiology Point-of-Care (POC) Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 36. China Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 37. China Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan Cardiology Point-of-Care (POC) Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea Cardiology Point-of-Care (POC) Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia Cardiology Point-of-Care (POC) Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 47. India Cardiology Point-of-Care (POC) Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 48. India Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 49. India Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 50. Cardiology Point-of-Care (POC) Diagnostics Industrial Chain
Figure 51. Cardiology Point-of-Care (POC) Diagnostics Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Table 1. Cardiology Point-of-Care (POC) Diagnostics Market Trends
Table 2. Cardiology Point-of-Care (POC) Diagnostics Market Drivers & Opportunity
Table 3. Cardiology Point-of-Care (POC) Diagnostics Market Challenges
Table 4. Cardiology Point-of-Care (POC) Diagnostics Market Restraints
Table 5. Global Cardiology Point-of-Care (POC) Diagnostics Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Cardiology Point-of-Care (POC) Diagnostics Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Cardiology Point-of-Care (POC) Diagnostics Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Cardiology Point-of-Care (POC) Diagnostics Product Type
Table 9. Key Companies Time to Begin Mass Production of Cardiology Point-of-Care (POC) Diagnostics
Table 10. Global Cardiology Point-of-Care (POC) Diagnostics Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiology Point-of-Care (POC) Diagnostics as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Cardiology Point-of-Care (POC) Diagnostics Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Cardiology Point-of-Care (POC) Diagnostics Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Cardiology Point-of-Care (POC) Diagnostics Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Cardiology Point-of-Care (POC) Diagnostics Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Region (2019-2024) & (%)
Table 27. Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Cardiology Point-of-Care (POC) Diagnostics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Cardiology Point-of-Care (POC) Diagnostics Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Cardiology Point-of-Care (POC) Diagnostics Sales Value, (2025-2030) & (US$ Million)
Table 31. Siemens Basic Information List
Table 32. Siemens Description and Business Overview
Table 33. Siemens Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
Table 34. Revenue (US$ Million) in Cardiology Point-of-Care (POC) Diagnostics Business of Siemens (2019-2024)
Table 35. Siemens Recent Developments
Table 36. Abbott Basic Information List
Table 37. Abbott Description and Business Overview
Table 38. Abbott Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
Table 39. Revenue (US$ Million) in Cardiology Point-of-Care (POC) Diagnostics Business of Abbott (2019-2024)
Table 40. Abbott Recent Developments
Table 41. Roche Basic Information List
Table 42. Roche Description and Business Overview
Table 43. Roche Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
Table 44. Revenue (US$ Million) in Cardiology Point-of-Care (POC) Diagnostics Business of Roche (2019-2024)
Table 45. Roche Recent Developments
Table 46. Opko Basic Information List
Table 47. Opko Description and Business Overview
Table 48. Opko Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
Table 49. Revenue (US$ Million) in Cardiology Point-of-Care (POC) Diagnostics Business of Opko (2019-2024)
Table 50. Opko Recent Developments
Table 51. GE Healthcare Basic Information List
Table 52. GE Healthcare Description and Business Overview
Table 53. GE Healthcare Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
Table 54. Revenue (US$ Million) in Cardiology Point-of-Care (POC) Diagnostics Business of GE Healthcare (2019-2024)
Table 55. GE Healthcare Recent Developments
Table 56. Samsung Health Basic Information List
Table 57. Samsung Health Description and Business Overview
Table 58. Samsung Health Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
Table 59. Revenue (US$ Million) in Cardiology Point-of-Care (POC) Diagnostics Business of Samsung Health (2019-2024)
Table 60. Samsung Health Recent Developments
Table 61. BioMerieux Basic Information List
Table 62. BioMerieux Description and Business Overview
Table 63. BioMerieux Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
Table 64. Revenue (US$ Million) in Cardiology Point-of-Care (POC) Diagnostics Business of BioMerieux (2019-2024)
Table 65. BioMerieux Recent Developments
Table 66. Abbott Basic Information List
Table 67. Abbott Description and Business Overview
Table 68. Abbott Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
Table 69. Revenue (US$ Million) in Cardiology Point-of-Care (POC) Diagnostics Business of Abbott (2019-2024)
Table 70. Abbott Recent Developments
Table 71. Terumo Basic Information List
Table 72. Terumo Description and Business Overview
Table 73. Terumo Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
Table 74. Revenue (US$ Million) in Cardiology Point-of-Care (POC) Diagnostics Business of Terumo (2019-2024)
Table 75. Terumo Recent Developments
Table 76. Accriva Basic Information List
Table 77. Accriva Description and Business Overview
Table 78. Accriva Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
Table 79. Revenue (US$ Million) in Cardiology Point-of-Care (POC) Diagnostics Business of Accriva (2019-2024)
Table 80. Accriva Recent Developments
Table 81. Akers Basic Information List
Table 82. Akers Description and Business Overview
Table 83. Akers Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
Table 84. Revenue (US$ Million) in Cardiology Point-of-Care (POC) Diagnostics Business of Akers (2019-2024)
Table 85. Akers Recent Developments
Table 86. Radiometer Basic Information List
Table 87. Radiometer Description and Business Overview
Table 88. Radiometer Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
Table 89. Revenue (US$ Million) in Cardiology Point-of-Care (POC) Diagnostics Business of Radiometer (2019-2024)
Table 90. Radiometer Recent Developments
Table 91. Response Biomedical Basic Information List
Table 92. Response Biomedical Description and Business Overview
Table 93. Response Biomedical Cardiology Point-of-Care (POC) Diagnostics Products, Services and Solutions
Table 94. Revenue (US$ Million) in Cardiology Point-of-Care (POC) Diagnostics Business of Response Biomedical (2019-2024)
Table 95. Response Biomedical Recent Developments
Table 96. Key Raw Materials Lists
Table 97. Raw Materials Key Suppliers Lists
Table 98. Cardiology Point-of-Care (POC) Diagnostics Downstream Customers
Table 99. Cardiology Point-of-Care (POC) Diagnostics Distributors List
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Cardiology Point-of-Care (POC) Diagnostics Product Picture
Figure 2. Global Cardiology Point-of-Care (POC) Diagnostics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Cardiology Point-of-Care (POC) Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 4. Cardiology Point-of-Care (POC) Diagnostics Report Years Considered
Figure 5. Global Cardiology Point-of-Care (POC) Diagnostics Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Cardiology Point-of-Care (POC) Diagnostics Revenue in 2023
Figure 7. Cardiology Point-of-Care (POC) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Cardiometabolic Monitoring Picture
Figure 9. Cardiometabolic Diagnostics Picture
Figure 10. Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Cardiology Point-of-Care (POC) Diagnostics Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Professional Diagnostic Centers
Figure 13. Product Picture of Hospitals/Critical Care Centers
Figure 14. Product Picture of Research Laboratories
Figure 15. Product Picture of Home Care
Figure 16. Global Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Cardiology Point-of-Care (POC) Diagnostics Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America Cardiology Point-of-Care (POC) Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 19. North America Cardiology Point-of-Care (POC) Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe Cardiology Point-of-Care (POC) Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe Cardiology Point-of-Care (POC) Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific Cardiology Point-of-Care (POC) Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific Cardiology Point-of-Care (POC) Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 24. South America Cardiology Point-of-Care (POC) Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 25. South America Cardiology Point-of-Care (POC) Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa Cardiology Point-of-Care (POC) Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa Cardiology Point-of-Care (POC) Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions Cardiology Point-of-Care (POC) Diagnostics Sales Value (%), (2019-2030)
Figure 29. United States Cardiology Point-of-Care (POC) Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 31. United States Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe Cardiology Point-of-Care (POC) Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 35. China Cardiology Point-of-Care (POC) Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 36. China Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 37. China Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan Cardiology Point-of-Care (POC) Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea Cardiology Point-of-Care (POC) Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia Cardiology Point-of-Care (POC) Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 47. India Cardiology Point-of-Care (POC) Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 48. India Cardiology Point-of-Care (POC) Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 49. India Cardiology Point-of-Care (POC) Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 50. Cardiology Point-of-Care (POC) Diagnostics Industrial Chain
Figure 51. Cardiology Point-of-Care (POC) Diagnostics Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232